Item 7.01.
|
Regulation FD Disclosure.
|
On April 30, 2019, the Company issued a press release announcing the Purchase Agreement. A copy of the press release is attached hereto as
Exhibit 99.1 and is incorporated by reference herein.
The information contained in Item 7.01 to this Current Report on Form
8-K
and Exhibit 99.1 attached hereto shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 as amended (the
Exchange Act
), or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing by the Company under the Exchange Act.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements in this communication regarding the proposed acquisition of the business of GenePOC by Meridian, including any statements regarding the
synergies, benefits and opportunities of the transaction, future opportunities for the combined company and products, future financial performance and any other statements regarding future expectations, beliefs, plans, objectives, financial
conditions, assumptions or future events or performance that are not historical facts are forward-looking statements made within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The words anticipate, believe, ensure, expect, if, intend, estimate, probable, project,
forecasts, predict, outlook, aim, will, could, should, would, potential, may, might, anticipate,
likely, plan, positioned, strategy, and similar expressions, and the negative thereof, are intended to identify forward-looking statements.